{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Effect of stomatitis on patients treated with adjuvant 5-fluorouracil and folinic acid for colorectal carcinoma", "pub_year": 1999, "citation": "GI Cancer-International Journal on Gastrointestinal Cancer 3 (1), 61-66, 1999", "author": "L Assersohn and A Webb and D Cunningham and P Ross and A Smith and A Norman and L Hey", "journal": "GI Cancer-International Journal on Gastrointestinal Cancer", "volume": "3", "number": "1", "pages": "61-66", "publisher": "[Switzerland?]: Harwood Academic Publishers; Basel, Switzerland; Langhorne, PA: Distributed by International Publishers Distributor, c1995-c2001.", "abstract": "Introduction The North Central Cancer Treatment Group (NCCTG) regimen of 5-Fluorouracil (5-FU) and folinic acid (FA) is one of the most widely used adjuvant treatments for colorectal carcinoma. This is a unique analysis of the regimen's side-effect of stomatitis and the impact it has on the quality of patients' lives. Methods Thirty consecutive patients receiving adjuvant 5-FU (425 mg/m (2)) and FA (20 mg/m (2)) for colorectal carcinoma had their mouths assessed at weekly intervals over the first treatment cycle. Detailed examinations were made using the Oral Mucosa Rating Scale (OMRS) in addition to the patients completing diary cards, symptom impact scores and quality of life questionnaires. Results Stomatitis was most severe one meek after commencing chemotherapy, Seventeen patients (59%) had a moderate/severe OMRS score over the four week period although their maximum CTC grading for stomatitis \u2026"}, "filled": true, "author_pub_id": "mSp4V_4AAAAJ:EfTNjLFZ3b0C", "num_citations": 1, "citedby_url": "/scholar?hl=en&cites=2006919632605662331", "cites_id": ["2006919632605662331"], "pub_url": "https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/7106298", "url_related_articles": "/scholar?oi=bibs&hl=en&oe=ASCII&q=related:e8w30sUC2hsJ:scholar.google.com/", "cites_per_year": {"1998": 1}}